Design Therapeutics
+$1.47 (+5.53%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell DSGN and other stocks, options, and ETFs commission-free!
About DSGN
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
CEO
Joao Siffert
Employees
15
Headquarters
Carlsbad, California
Founded
2017
DSGN Key Statistics
Market Cap
1.59B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
101.77K
High Today
$28.10
Low Today
$26.62
Open Price
$26.62
Volume
40.82K
52 Week High
$50.50
52 Week Low
$18.81
DSGN Earnings
Q1 FY21
Estimated
— per share
Actual
Expected May 18, Pre-Market